Requesting alternate product therapy
For exceptional access to plasma protein products not carried on the Canadian Blood Services product formulary, a medical review is required.
Clinicians can request access to the Canadian Blood Services medical review process for alternate product therapy, on behalf of patients who are not able to tolerate specific plasma protein products. Each patient specific request will be reviewed within 30 days, unless indicated as urgent. Submit all requests to email@example.com.